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Background: Hypotension is common during spinal anesthesia (SA) and is caused by a 
decrease in systemic vascular resistance (SVR) and/or cardiac output (CO). The effect of the 
dose of bupivacaine administered intrathecally on the changes in CO in elderly patients is largely 
unknown. This study investigated the hemodynamic effect of SA in elderly patients by studying 
the effect of two different dosages of intrathecal bupivacaine.
Methods: This prospective cohort study included 64 patients aged >65 years scheduled for 
procedures under SA; the patients received either 15 mg bupivacaine (the medium dose [MD] 
group) or 10 mg bupivacaine and 5 μg sufentanil (the low dose [LD] group). Blood pressure 
and CO were monitored throughout the procedure using Nexfin™, a noninvasive continuous 
monitoring device using a finger cuff.
Results: Thirty-three patients received MD and 31 received LD and there was no mean differ-
ence in baseline hemodynamics between the groups. On an average, the CO decreased 11.6% in 
the MD group and 10.0 % in the LD group. There was no significant change in SVR. Incidence 
of a clinically relevant decrease in stroke volume (SV) (>15% from baseline) was 67% in the 
MD and 45% in the LD groups (P<0.05).
Conclusion: CO and blood pressure decreased significantly after the onset of SA in elderly 
patients. This is mainly caused by a decrease in SV and not by a decrease in SVR. There was 
no difference in CO and blood pressure change between dosages of 10 or 15 mg bupivacaine.
Keywords: cardiac output, intrathecal anesthesia, local anesthetics, dose, finger blood pressure 
measurement
Introduction
Hypotension is a common side effect of spinal anesthesia (SA) and it occurs in 16–33% 
of cases.1 This response is exaggerated in the elderly where a negative influence on 
a relatively higher resting sympathetic tone and decreased baroreceptor activity may 
explain the higher incidence of hypotension in response to SA.2,3 Hypotension after the 
onset of SA is thought to be caused by either a decrease in systemic vascular resistance 
(SVR) or cardiac output (CO) or both.
Until recently, CO measurement required invasive monitoring, which is unsuitable 
in awake patients having SA for short procedures. Therefore, studies regarding factors 
that might influence the hemodynamic effect of SA on CO, eg, doses of intrathecal 
local anesthetics, are limited.4,5 Moreover, most CO monitors produce only intermit-
tent measurements thereby providing only limited understanding of fast hemodynamic 
changes.
correspondence: charlotte hofhuizen
Department of critical care, Radboud 
University Medical center, PO Box 
9101, nijmegen 6500 hB, nijmegen, 
The netherlands
Tel +31 24 361 7273
Fax +31 24 363 5156
email charlotte.hofhuizen@radboudumc.nl
Journal name: Local and Regional Anesthesia
Article Designation: Original Research
Year: 2019
Volume: 12
Running head verso: Hofhuizen et al
Running head recto: Hofhuizen et al
DOI: http://dx.doi.org/10.2147/LRA.S193925
 
Lo
ca
l a
nd
 R
eg
io
na
l A
ne
st
he
sia
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
1.
17
4.
24
8.
11
 o
n 
15
-A
pr
-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Local and Regional Anesthesia 2019:12submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
20
hofhuizen et al
Nexfin™ (Edwards Lifesciences, Irvine, CA, USA) 
provides a continuous, noninvasive blood pressure and 
CO measurement using a finger cuff. This device does not 
bring inconvenience to patients making it clinically suitable 
for monitoring awake patients having regional anesthesia. 
Several recent studies have shown the device to be suf-
ficiently accurate in the measurement of absolute CO and 
blood pressure values as well as in tracking CO and blood 
pressure changes.6–8
In this study we have investigated the hemodynamic 
effects of SA during uncomplicated surgical procedures. 
Since we hypothesize that the hemodynamic effects would be 
dose-dependent, we evaluated two different dosages of local 
anesthetics to provide a better understanding of the underly-
ing cause of hypotension after the onset of SA.
Patients and methods
Patients
We performed a prospective double cohort study. The Regional 
Ethics Committee in Nijmegen, the Netherlands, responsible 
for medical research in humans (Ethical Committee No. 
20091171) approved the study and the need for informed con-
sent was waived because of the purely observational nature of 
the study. The research was performed in accordance with the 
Declaration of Helsinki. Participants recruited were individuals 
admitted for elective surgery to a 500-bed teaching hospital 
in Nijmegen, the Netherlands. The study period was from 
December 2009 to January 2011. Seventy-one consecutive 
patients, American Society of Anaesthesiologists class I–III, 
aged ≥65 years scheduled for elective orthopedic, general, or 
vascular surgery using SA were included. Patients with cardiac 
arrhythmia, digital ischemia, allergic reactions to opiates or 
local anesthetics, perioperative blood loss that exceeded 1 L, 
and New York Heart Association class III–IV congestive heart 
failure were excluded from the study.
sA
Since the main focus of this study was to evaluate the hemo-
dynamic effect of SA, we performed an observational study 
in patients receiving local anesthetics intrathecally. To provide 
a better understanding of their effect on hemodynamics, we 
observed two different intrathecal dosage groups. For the 
medium dose (MD), we included patients receiving 15 mg 
bupivacaine intrathecally. For the low dose (LD), we chose to 
study the lowest intrathecal dose of bupivacaine that would 
with great probability still provide effective anesthesia for 
certain long procedures such as hip surgery or vascular sur-
gery. Five microgram Sufenta™ was regularly added to the 
LD to ensure adequate intensity and duration of analgesia and 
to administer an identical volume intrathecally.9 We compared 
patients receiving 10 mg bupivacaine with 5 μg Sufenta™ 
to patients receiving ‘medium’ intrathecal dose of 15 mg 
bupivacaine. Extension of anesthesia to the higher thoracic 
dermatomes may lead to bradycardia due to blockage of the 
cardiac sympathetic accelerator fibers arising from the first 
four thoracic segments. To avoid this, as a high spinal block 
would surely have an effect on CO, SA was performed at 
L2-3 or L3-4 and never at a higher interspace.10 For clarity, 
we named the 10 mg bupivacaine regime as LD and the 15 
mg bupivacaine regime as MD. The dose of bupivacaine, LD 
or MD, was based upon the clinical decision of the attending 
anesthesiologist based on patient characteristics and personal 
preference, and there was no randomization. The research 
team was blinded for the dose administered intrathecally.
study protocol
One hour before surgery, patients received 1,000 mg acet-
aminophen and anxious patients received either 7.5 mg mid-
azolam or 10 mg oxazepam orally. The patients were fasted 
overnight and oral fluid intake was allowed for up to 2 hours 
before the procedure. Neither IV fluid was infused before 
entering the study, nor were any prophylactic vasoactive drugs 
administered (like, ephedrine or atropine). After arrival in the 
operating room intravenous access was established. Periop-
erative hemodynamic monitoring included the noninvasive 
measurement of heart rate (HR) using electrocardiographic 
recording electrodes, noninvasive blood pressure using oscil-
lometry, and a pulse oximeter. The noninvasive arterial blood 
pressure (ABP
NI
) and CO measurement (CO
NI
) were obtained 
using a finger cuff adjusted to the size of the index finger of 
the patient according to the guidelines of the manufacturer 
and connected to the Nexfin™ monitor. This noninvasive 
device is based on the principle of Peňaz and measures the 
diameter of the finger’s artery using an inflatable finger cuff 
and a built-in photoelectric plethysmograph.11 From this 
signal, blood pressure in the brachial artery is reconstructed. 
Nexfin™ calculates beat-to-beat CO by dividing the area 
under the systolic portion of the arterial pressure curve by 
the aortic input impedance, which is determined from a 
three-element Windkessel model described by Westerhof et 
al12 using the influence of the patient’s age, height, weight, 
and sex on aortic mechanical properties.
SA was performed with the patient in sitting position, a 
27-gauge pencil-point needle was inserted in the subarach-
noid space at the L2-3 or L3-4 interspace. After obtaining 
free flow of clear cerebrospinal fluid either 3 mL bupivacaine, 
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5 mg/mL (MD) or an admixture of 2 mL bupivacaine 0.5% 
and 1 mL sufentanil, 5 μg/mL (LD) was injected with the 
spinal needle bevel facing cephalad. Immediately after injec-
tion, patients were placed in the supine position.
Hypotension was defined as a decrease in mean arterial 
pressure (MAP) >25% from baseline value or systolic arte-
rial pressure (SAP <100 mmHg, and was treated with 5 mg 
IV bolus ephedrine and repeated every 3 minutes until the 
hypotension resolved. Bradycardia was defined as a HR <40 
beats per minute and was treated with atropine 0.5 mg IV. 
During surgery, isotonic saline 0.9% solution was infused 
at a rate of 1.5 mL/kg/hour. If blood loss exceeded 300 mL 
this was compensated using hydroxyethyl starch solution 
(130/0.46% hydroxyethyl starch solution; Fresenius Kabi, 
Bad Homburg vor der Höhe, Germany).
Measurements
A baseline ABP
NI
 and CO
NI
 measurements were performed 
during 3 minutes in supine position before commencing the 
SA procedure. Hemodynamic data were recorded and stored 
electronically using the Nexfin™ and analyzed offline. After 
performance of SA, the patient was repositioned in supine 
position and ABP
NI
 and CO
NI
 were measured continuously 
until the end of surgery as measurements beyond this point, 
during transport to the recovery room, etc, would introduce 
movement artifacts and bias due to replacement of the finger 
cuff. The sensory block level was tested at 5-minute inter-
vals using a cold discrimination. Time to discharge from the 
recovery room to the ward, according to the Post Anesthesia 
Care Unit  protocol after regression of sensory level to Th12, 
Aldrete score ≥9 and NRS <4, was recorded.13
statistical analysis
A decrease in stroke volume (SV) is one of the most important 
possible sources of hypotension after SA. However, to our 
knowledge, there are no studies regarding the effect of the 
dosage of intrathecal local anesthetics on SV, and therefore, 
we used a composite outcome parameter, CO, as the primary 
effect parameter 30 minutes after the onset of anesthesia. 
Based on a previous study we expected the difference in CO 
between the two study groups to be 0.75 L/min.5 We calculated 
that a total sample size of 60 patients would allow us to detect 
this CO difference based on a SD of 20% and a 5% type 1 
error risk.14 To allow for potential dropouts from treatment, we 
included 71 patients. A decrease of >25% in MAP or SAP or 
a decrease in SV >15% was considered clinically significant.
A MedCalc® software package (MedCalc Software, 
Ostend, Belgium) was used for statistical analysis. Patient 
characteristics are expressed as mean and range, and hemo-
dynamic data as mean and SD. Assumption of normality 
was checked using a Kolmogorov–Smirnov test. To compare 
demographic and hemodynamic data from baseline Student’s 
t-test, chi-squared test, and one-way ANOVA were used. 
P<0.05 was considered statistically significant.
Hemodynamic variables were stored on the Nexfin™ 
monitor and analyzed offline. We used 30-second time 
intervals to analyze hemodynamic effects of SA that were 
sampled at various intervals during the surgical procedure 
until 40 minutes after the onset of SA.
Results
Seventy-one patients were included in the study. In three 
patients a good quality noninvasive finger signal could 
not be obtained. Four patients were excluded from further 
analysis because perioperative blood loss exceeded 1 L, this 
resulted in 64 patients with a complete data set (Figure 1). 
Patient characteristics are depicted in Table 1. The majority 
of patients underwent hip surgery, either elective replace-
ment or repair after a hip fracture. Data collection ended at 
the end of surgery with a mean duration of 40 minutes. Two 
patients required supplemental intravenous analgesia, one 
in each study group. Baseline patient characteristics and 
hemodynamic values did not differ statistically between the 
two groups (Table 2).
The course of changes in SV after initiation of SA is 
depicted in Figure 2. Mean hemodynamic changes that 
occurred during the course of measurements are depicted in 
Table 3. SV decreased 11% (P<0.001) in the MD group and 
decreased 8% in the LD group (P=0.01). An SV decrease of 
>15% occurred in 67% and 45% of patients in the MD and 
the LD group, respectively (Table 4).
Mean dosage of ephedrine was 7.8 mg in the MD group 
and 4.7 mg in the LD group (P=0.14). Three patients in the 
MD group required rescue medication (phenylephrine) to 
maintain blood pressure, no patients in the LD group had 
hypotension unresponsive to ephedrine. Baseline hemody-
namic values did not differ between patients who did and did 
not require ephedrine (Table 5). Changes in blood pressure, 
HR, and CO were not influenced by blood loss or the height 
of sensory block.
Discussion
Blood pressure decreases significantly after onset of SA. In 
this study, this was caused by a decrease in CO and not by a 
decrease in SVR. There was no difference in mean decrease 
in CO and MAP between the two dosage groups. Nexfin™ 
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Figure 1 Flow diagram of trial procedure.
Note: The patients with >1 L blood loss were excluded.
Abbreviations: LD, low dose; MD, medium dose.
71 patients
assessed for
eligibility
Patients in MD
group (n=36)
Patients in LD
group (n=32)
>1 L blood loss
(n=3)
>1 L blood loss
(n=1)
Analyzed in MD
group (n=33)
Analyzed in LD
group (n=31)
Excluded
because of
inadequate
Nexfin™ signal
(n=3)
Table 1 Patient characteristics
MD (n=33) LD (n=31) P-value
Age (years), mean (range) 74 (65–89) 74 (65–86) ns
sex (M/F), n/n 10/23 12/19 ns
BMi (kg/m2), mean (range) 26.6 (19.4–35.6) 26.1 (20.0–33.5) ns
AsA (i/ii/iii), n/n/n 4/24/8 4/22/5 ns
Type of surgery, n
Orthopedic
Vascular
general
27
3
3
26
1
4
sensory level, mean (range) Th9 (Th4–Th12) Th9 (Th6–L1) ns
Blood loss (mL), mean (range) 222 (30–600) 218 (20–500) ns
Time in recovery room (min), mean (range) 94 (30–180) 81 (30–180) ns
ephedrine (mg), mean (range) 7.8 (0–40) 4.7 (0–15) ns
ephedrine, n (%) 19 (57.6%) 13 (41.9%) ns
Rescue medication, n 3 0 ns
Note: Data are expressed as mean and range unless otherwise stated.
Abbreviations: AsA, American society of Anaesthesiologists; BMi, body mass index; LD, low dose; MD, medium dose; NS, not significant.
proved to be suitable to demonstrate different hemodynamic 
effects of two spinal anesthetic regimes.
Several mechanisms are proposed to be the cause of the 
hypotensive response after SA. First, sympathetic blockage 
from T1 to L2 with subsequent arteriolar vasodilation leads to 
a reduction in SVR, contributing to intraoperative hypotension. 
This decrease in SVR is often thought to be the main cause of 
hypotension after SA. Second, a decrease in venous vasomo-
tor tone increases venous pooling and consequently reduces 
venous return, thereby decreasing CO. Finally, the physiologi-
cal hemodynamic reserve capacity decreases with age, and 
limited cardiovascular compensation mechanisms contribute 
to a decline in CO and blood pressure in response to SA.15
After the onset of SA, CO decreased in both groups as a 
result of a decrease in SV. The incidence of a clinically rel-
evant decrease in SV and SAP was higher in the MD group 
compared to the LD group. Since blood pressure (afterload) 
decreased and a change in cardiac muscle contractility was 
unlikely, the only explanation for the decrease in SV was a 
reduction in venous return.16,17 Indeed, a study in dogs showed 
that SA causes a decline in mean systemic filling pressure 
(MSFP). This decrease in MSFP is caused by a redistribu-
tion of blood volume to the splanchnic vasculature and to 
the lower extremities as a result of sympathetic ‘denervation’ 
induced by local anesthetics used for SA.3,18 This causes a 
reduction in venous return, and therefore, a decrease in SV.19,20
This decrease in SV was not compensated by an increase 
in HR to maintain CO. Possible explanations are a blunted 
β-adrenoreceptor response that is observed in elderly 
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Table 2 Baseline hemodynamic variables
Baseline MD (SD) LD (SD) P-value
cO (L/min)
sV (mL)
MAP (mmhg)
sAP (mmhg)
DAP (mmhg)
hR (b/min)
sVR (dyn·s/cm5)
4.32 (1.3)
64 (16)
99 (17)
141 (30)
74.5 (11.5)
68 (14)
1,905 (625)
4.49 (0.89)
67 (17)
99 (16)
140 (25)
74.6 (11.8)
69 (11)
1,838 (503)
ns
ns
ns
ns
ns
ns
ns
Notes: Data are expressed as mean (sD).
Abbreviations: cO, cardiac output; DAP, diastolic arterial pressure; hR, heart 
rate; LD, low dose; MAP, mean arterial pressure; MD, medium dose; ns, not 
significant; SAP, systolic arterial pressure; SV, stroke volume; SVR, systemic vascular 
resistance.
Figure 2 change of sV in the MD and LD groups at 10, 20, and 30 minutes after sA.
Notes: Baseline values are represented as 100%, white boxes represent MD, gray 
boxes represent LD, and the dots represent outliers.
Abbreviations: LD, low dose; MD, medium dose; sA, spinal anesthesia; sV, stroke 
volume.
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Table 3 Maximum increases and decreases in hemodynamic 
variables and mean decrease at 30 minutes after onset of sA
MD (SD) LD (SD) P-value
cO
Percent change at 10 minutes
Percent change at 20 minutes
Percent change at 30 minutes
5.9 (12.1)*
10.1 (10.9)*
11.6 (13.6)*
5.3 (16.1)
12.4 (16.6)*
12.9 (15.2)*
ns
ns
ns
sV
Percent change at 10 minutes
Percent change at 20 minutes
Percent change at 30 minutes
3.3 (13.3)
7.3 (13.8)*
10.7 (16.2)*
1.5 (18.9)
4.9 (20.4)*
8.0 (18.9)*
ns
ns
ns
MAP
Percent change at 10 minutes
Percent change at 20 minutes
Percent change at 30 minutes
4.6 (14.3)
6.5 (15.4)
8.4 (21.2)*
2.3 (11.8)
10.4 (15.3)*
9.9 (15.1)*
ns
ns
ns
sAP
Percent change at 10 minutes
Percent change at 20 minutes
Percent change at 30 minutes
3.9 (15.1)
7.6 (15.2)*
12.3 (20.4)*
0.2(15.6)
7.8 (17.2)*
9.9 (17.8)*
ns
ns
ns
DAP
Percent change at 10 minutes
Percent change at 20 minutes
Percent change at 30 minutes
0.9 (14.9)
1.3 (16.8)
4.9 (18.4)*
0.8 (11.8)
5.0 (13.6)
5.8 (13.7)*
ns
ns
ns
hR
Percent change at 10 minutes
Percent change at 20 minutes
Percent change at 30 minutes
2.2 (9.1)
1.5 (12.2)
1.0 (16.0)
3.9 (8.8)
6.8 (11.8)*
3.7 (14.9)
ns
ns
ns
sVR
Percent change at 10 minutes
Percent change at 20 minutes
Percent change at 30 minutes
7.4 (27.3)
7.5 (20.7)
5.0 (23.0)
8.2 (23.15)
8.6 (32.4)
5.6 (22.9)
ns
ns
ns
Notes: Data are expressed as mean (sD). *P≤0.05 compared to baseline.
Abbreviations: cO, cardiac output; DAP, diastolic arterial pressure; hR, heart 
rate; LD, low dose; MAP, mean arterial pressure; MD, medium dose; ns, not 
significant; SAP, systolic arterial pressure; SA, spinal anesthesia; SV, stroke volume; 
sVR, systemic vascular resistance.
Table 4 Percentage of patients developing clinically significant 
hemodynamic changes in both study groups
MD LD P-value
sV decrease >15% 23/33 (67%) 14/31 (45%) 0.047
MAP decrease >25% 12/33 (37%) 6/31 (19%) ns
sAP decrease >25% 16/33 (48%) 6/31 (19%) 0.014
Abbreviations: LD, low dose; MAP, mean arterial pressure; MD, medium dose; 
NS, not significant; SAP, systolic arterial pressure; SV, stroke volume.
patients,21 use of beta-adrenergic blocking medication, or 
blockade of the sympathetic cardio-accelerator fibers caused 
by SA,3 although very few patients had a peak sensory block 
height ≥ Th5. However, a sympathetic block can extend above 
2–6 dermal segments with sensory loss.22
Several previous studies have identified a decrease in 
SVR as the main determinant of hypotension. In these studies 
patients received fluid loading just before or after the onset of 
SA.16,18,23 This fluid loading can significantly increase stressed 
volume and, therefore, venous return. In individuals to whom 
preload is administered as a ‘standard procedure’, SV and 
CO remain unchanged after the onset of SA. In our study, 
patients did not receive any fluid loading, possibly explain-
ing why hypotension was mainly caused by a decrease in SV 
and not by a decrease in SVR. Also, fluid loading in itself 
may cause a decrease in SVR because of hemodilution with 
a decline in viscosity, which explains why an increase in CO 
may not necessarily lead to an increase in blood pressure.24,25
The mean decrease in CO was 11%, 40 minutes after 
the onset of SA. Other studies reported similar results with 
CO decreases ranging from 8%–14% in similar research 
populations.18,26,27 We did not observe a significant differ-
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ence in changes in CO between the two dosage groups. This 
was also found in a previous study in an obstetric popula-
tion.4 A correlation between change in CO and dosage of 
subarachnoid bupivacaine-sufentanil has been suggested.5 
However, in the latter study lower dosages of subarachnoid 
bupivacaine (7.5 and 12.5 mg) were used, study population 
was small and a different noninvasive CO monitor was used, 
impedance cardiography. The administration of vasopressor 
medication might blur statistical difference in CO between 
the two groups. Vasopressor medication exerts an important 
part of its action by increasing venous return by increasing 
MSFP and therefore CO.28,29
In this study, hypotension was caused by a decrease in SV. 
Low SV can be treated with volume therapy; the administra-
tion of vasopressor medication likewise increases SV due 
to an increase in preload. However, a clinical implication of 
this study can be that if a patient remains hypotensive despite 
vasopressor medication, administration of intravenous fluid 
is indicated to increase SV and consequently blood pressure. 
This hypothesis is supported by an earlier study in elderly 
patients undergoing hip surgery SA. Lithium dilution car-
diac output (LiDCO, Lido Group, London, UK)-based fluid 
therapy was applied to optimize SV, patients required very 
little vasopressor medication as a consequence.30 This is fur-
ther supported by previous studies in obstetric patients, where 
co-loading, infusing fluid immediately after the onset of SA 
with either crystalloid or colloid fluids, led to an increased 
hemodynamic stability.31,32 We chose to administer no fluids 
to be able to evaluate the hemodynamic response to SA with 
minimal effect on preload. Moreover, the administration of 
overzealous and unnecessary fluid can lead to complications 
such as bladder retention, pulmonary edema, and increased 
length of stay.33
Several limitations to our study should be noted. First, 
because our main focus was to study the hemodynamic effect 
of SA using only a finger cuff, the decision whether to allocate 
patients to the MD or LD group was left at the discretion of 
Table 5 Baseline hemodynamic values of patients who required ephedrine and patients who did not require ephedrine
With ephedrine (SD) Without ephedrine (SD) P-value
cO (L/min) 4.23 (1.0) 4.59 (1.15) ns
sV (mL) 63.1 (14.7) 68.4 (17.6) ns
MAP (mmhg) 99.3 (18.1) 100.1 (16.2) ns
sAP (mmhg) 140.4 (29.2) 142.8 (28.4) ns
DAP (mmhg) 75.2 (12.7) 74.5 (10.7) ns
hR (b/min) 68.0 (13.2) 68.4 (11.9) ns
sVR (dyn·s/cm5) 1,964.9 (624.7) 1,819.3 (512) ns
Notes: Data are expressed as mean (sD).
Abbreviations: CO, cardiac output; DAP, diastolic arterial pressure; HR, heart rate; MAP, mean arterial pressure; NS, not significant; SV, stroke volume; SAP, systolic 
arterial pressure; sVR, systemic vascular resistance.
the attending anesthesiologist based on the patient charac-
teristics and type of surgery due to patient safety. This may 
introduce a selection bias. However, after evaluation, baseline 
patient characteristics, types of surgery, and hemodynamic 
variables did not differ between the two dosage groups. How-
ever, small differences between patients such as frailty are 
not represented in “crude” scores such as American Society 
of Anaesthesiologists class and age. Although the range of 
sensory block was quite large, this is comparable with previ-
ous literature.9 A second limitation of this study is the lack of 
knowledge of the precision of Nexfin™. Although Nexfin™ 
has been shown to accurately provide CO measurement and 
show acceptable CO tracking capabilities,6,34 its precision is 
uncertain due to difficulties in previous studies evaluating 
this device, such as unknown precision of the reference tech-
nique, small sample sizes, specific patient study groups, and 
the studies’ COs to determine accuracy range from very low 
to very high.35,36 This makes Nexfin™ possibly unsuitable to 
demonstrate subtle CO differences. However, Nexfin™ is the 
only CO measuring device that is adequately validated in a 
clinical setting and measures continuously and noninvasively, 
making it applicable to monitor awake patients.
Conclusion
Blood pressure decreased significantly after the onset of SA 
without fluid preloading in elderly patients. The hypotension 
that occurred was caused by a decrease in SV but not by a 
decrease in SVR. There was no difference in CO and blood 
pressure change between dosages of 10 or 15 mg bupivacaine.
Abbreviations
ABP
NI
, noninvasive blood pressure measurement using Nex-
fin™; CO, cardiac output; CO
NI
, noninvasive cardiac output 
measurement using Nexfin™; LD, low dose; MD, medium 
dose; MAP, mean arterial pressure; SA, spinal anesthesia; 
SV, stroke volume; SAP, systolic arterial pressure; SVR, 
systemic vascular resistance.
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